Empagliflozin is a novel sodium glucose co-transporter-2 (SGLT-2) inhibitor, which is useful for improving glycaemic control in adults with type-2 diabetes mellitus.
The patent also covers the efficacy of the herbal composition in the management of metabolic syndrome disorders
The yoga protocol included gentle and restorative yoga postures(asana) with regular periods of relaxation and pranayama
48-week data from MOMENTUM phase III clinical trial show momelotinib maintained total symptom response
35 million mosquito nets supplied to countries in sub-Saharan Africa through partners
The company will set-up a pharmaceuticals formulation manufacturing unit with an investment of Rs. 100 crore in Odisha
Tambe has been with Biocon since 1997 and has held diverse leadership and operational roles.
The new eye hospital in Vashi is ASG’s second in the Mumbai Metropolitan Region (MMR) and the sixth in Maharashtra
New Lexington, Massachusetts facility to provide customer education and collaboration opportunities
Results showed a statistically significant and clinically meaningful improvement in investigator-assessed progression-free survival
Subscribe To Our Newsletter & Stay Updated
